Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ODE director

This article was originally published in The Gray Sheet

Executive Summary

Short list of roughly a half dozen candidates for the post of director of FDA's office of device evaluation are undergoing final interviews with center director Bruce Burlington. FDA's search committee narrowed down the list from a pool of about 50 applicants ("The Gray Sheet" July 5, In Brief). The short list of clinicians and engineers includes candidates from inside and outside the agency. A decision may be made as early as the week of Aug. 9.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT001022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel